Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FD Technologies Ltd. Regulatory Filings 2019

May 17, 2019

6234_rns_2019-05-17_29598dfc-1188-423b-b865-e76fddce79e8.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3334Z

First Derivatives PLC

17 May 2019

17 May 2019

First Derivatives plc

("FD" or the "Group")

Statement regarding Brian Conlon

FD (AIM: FDP.L, Euronext Growth: FDP.I) announces that Brian Conlon, Chief Executive Officer, has recently been diagnosed with cancer. Brian will remain as Chief Executive Officer during his ongoing weekly treatment, which includes chemotherapy. This treatment is expected to last a number of months.

Seamus Keating, Chairman of FD, said: "The Board has set a clear strategy and the Executive Committee, led by Brian, has delivered strong execution of that strategy year-on-year. During the period of his treatment I will provide additional executive and governance support and I am confident that Brian and his team will continue to execute the Group's growth plans successfully."

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations
+44(0)28 3025 2242

www.firstderivatives.com
Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence
+44 (0)20 7597 5970
Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Finbarr Griffin
+353 1 667 0420
FTI Consulting

Matt Dixon

Dwight Burden

Darius Alexander

Niamh Fogarty
+44 (0)20 3727 1000

About FD

FD is a global technology provider with 20 years of experience working with some of the world's largest finance, technology, retail, pharma, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 14 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.

For further information, please visit www.firstderivatives.com and www.kx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

STRAFMFTMBABBBL